<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="int-interactant" /><meta name="keywords" content="" /><title>Hydrocortisone: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="41001i491.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="41001i491.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=41001i491.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="41001.htm">Appendix 1 Interactions</a> &gt; <a href="53178.htm">List of drug interactions</a> &gt; <a href="41001i484.htm">Corticosteroids</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="41001i497.htm" title="Previous: Fluticasone">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="41001i492.htm" title="Next: Methylprednisolone">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_41001i491">Hydrocortisone</h1><div id="pC" class="jN"><p class="int-specific-drug-name"><b>Hydrocortisone</b>
          has no specific interaction information.
        </p><p>Hydrocortisone belongs to <b>Corticosteroids</b>
          and will have the following interactions:
        </p><div>Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</div><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody>
















































<tr><td><a href="41001i2.htm">ACE Inhibitors</a></td><td> corticosteroids antagonise hypotensive effect of ACE inhibitors </td><td></td></tr><tr><td><a href="41001i551.htm">Acetazolamide</a></td><td>increased risk of hypokalaemia when  corticosteroids given with acetazolamide </td><td></td></tr><tr><td><a href="41001i15.htm">Adrenergic Neurone Blockers</a></td><td> corticosteroids antagonise hypotensive effect of adrenergic neurone blockers </td><td></td></tr><tr><td><a href="41001i21.htm">Aldesleukin</a></td><td class="cBV"><b>avoidance of  corticosteroids advised by manufacturer of aldesleukin </b></td><td></td></tr><tr><td><a href="41001i26.htm">Alpha-blockers</a></td><td> corticosteroids antagonise hypotensive effect of alpha-blockers </td><td></td></tr><tr><td><a href="41001i290.htm">Amphotericin</a></td><td class="cBV"><b>increased risk of hypokalaemia when  corticosteroids given with amphotericin—avoid concomitant use unless corticosteroids needed to control reactions</b></td><td>Close monitoring required with concomitant administration of nephrotoxic drugs or cytotoxics</td></tr><tr><td><a href="41001i107.htm">Angiotensin-II Receptor Antagonists</a></td><td> corticosteroids antagonise hypotensive effect of angiotensin-II receptor antagonists </td><td></td></tr><tr><td><a href="41001i264.htm">Antidiabetics</a></td><td> corticosteroids antagonise hypoglycaemic effect of antidiabetics </td><td></td></tr><tr><td><a href="41001i361.htm">Aspirin</a></td><td>increased risk of gastro-intestinal bleeding and ulceration when  corticosteroids given with aspirin , also corticosteroids reduce plasma concentration of salicylate</td><td></td></tr><tr><td><a href="41001i440.htm">Beta-blockers</a></td><td> corticosteroids antagonise hypotensive effect of beta-blockers </td><td>Since systemic absorption may follow topical application of beta-blockers to the eye the possibility of interactions, in particular, with drugs such as verapamil should be borne in mind</td></tr><tr><td><a href="41001i465.htm">Calcium Salts</a></td><td> corticosteroids reduce absorption of calcium salts </td><td><i>see also</i> Antacids</td></tr><tr><td><a href="41001i466.htm">Calcium-channel Blockers</a></td><td> corticosteroids antagonise hypotensive effect of calcium-channel blockers </td><td>Dihydropyridine calcium-channel blockers include amlodipine, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine, and nimodipine</td></tr><tr><td><a href="41001i277.htm">Carbamazepine</a></td><td class="cBV"><b>metabolism of  corticosteroids accelerated by carbamazepine (reduced effect)</b></td><td></td></tr><tr><td><a href="41001i478.htm">Cardiac Glycosides</a></td><td>increased risk of hypokalaemia when  corticosteroids given with cardiac glycosides </td><td></td></tr><tr><td><a href="41001i482.htm">Clonidine</a></td><td> corticosteroids antagonise hypotensive effect of clonidine </td><td></td></tr><tr><td><a href="41001i220.htm">Coumarins</a></td><td class="cBV"><b> corticosteroids may enhance or reduce anticoagulant effect of coumarins (high-dose corticosteroids enhance anticoagulant effect)</b></td><td>Change in patient’s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</td></tr><tr><td><a href="41001i522.htm">Diazoxide</a></td><td> corticosteroids antagonise hypotensive effect of diazoxide </td><td></td></tr><tr><td><a href="41001i524.htm">Diuretics</a></td><td> corticosteroids antagonise diuretic effect of diuretics </td><td></td></tr><tr><td><a href="41001i539.htm">Diuretics, Loop</a></td><td>increased risk of hypokalaemia when  corticosteroids given with loop diuretics </td><td></td></tr><tr><td><a href="41001i525.htm">Diuretics, Thiazide and related</a></td><td>increased risk of hypokalaemia when  corticosteroids given with thiazides and related diuretics </td><td></td></tr><tr><td><a href="41001i169.htm">Erythromycin</a></td><td>metabolism of  corticosteroids possibly inhibited by erythromycin </td><td>Interactions do not apply to small amounts of erythromycin used topically</td></tr><tr><td><a href="41001i1180.htm">Histamine</a></td><td>avoidance of  corticosteroids advised by manufacturer of histamine </td><td></td></tr><tr><td><a href="41001i763.htm">Hydralazine</a></td><td> corticosteroids antagonise hypotensive effect of hydralazine </td><td></td></tr><tr><td><a href="41001i165.htm">Isoniazid</a></td><td> corticosteroids possibly reduce plasma concentration of isoniazid </td><td></td></tr><tr><td><a href="41001i302.htm">Itraconazole</a></td><td>metabolism of  corticosteroids possibly inhibited by itraconazole </td><td></td></tr><tr><td><a href="41001i298.htm">Ketoconazole</a></td><td>metabolism of  corticosteroids possibly inhibited by ketoconazole </td><td></td></tr><tr><td><a href="41001i611.htm">Methyldopa</a></td><td> corticosteroids antagonise hypotensive effect of methyldopa </td><td></td></tr><tr><td><a href="41001i1173.htm">Mifamurtide</a></td><td>avoidance of  corticosteroids advised by manufacturer of mifamurtide </td><td></td></tr><tr><td><a href="41001i614.htm">Mifepristone</a></td><td>effect of  corticosteroids (including <i>inhaled</i> corticosteroids) may be reduced for 3–4 days after mifepristone </td><td></td></tr><tr><td><a href="41001i764.htm">Minoxidil</a></td><td> corticosteroids antagonise hypotensive effect of minoxidil </td><td></td></tr><tr><td><a href="41001i615.htm">Moxonidine</a></td><td> corticosteroids antagonise hypotensive effect of moxonidine </td><td></td></tr><tr><td><a href="41001i631.htm">Nitrates</a></td><td> corticosteroids antagonise hypotensive effect of nitrates </td><td></td></tr><tr><td><a href="41001i60.htm">NSAIDs</a></td><td>increased risk of gastro-intestinal bleeding and ulceration when  corticosteroids given with NSAIDs </td><td><i>See also </i>Aspirin. Interactions do not generally apply to topical NSAIDs
</td></tr><tr><td><a href="41001i636.htm">Oestrogens</a></td><td>plasma concentration of  corticosteroids increased by oral contraceptives containing oestrogens </td><td>Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="4552.htm#_120026">section 7.3.1</a></td></tr><tr><td><a href="41001i625.htm">Pancuronium</a></td><td> corticosteroids possibly antagonise effects of pancuronium </td><td></td></tr><tr><td><a href="41001i223.htm">Phenindione</a></td><td> corticosteroids may enhance or reduce anticoagulant effect of phenindione </td><td>Change in patient’s clinical condition particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control  </td></tr><tr><td><a href="41001i437.htm">Phenobarbital</a></td><td class="cBV"><b>metabolism of  corticosteroids accelerated by phenobarbital (reduced effect)</b></td><td></td></tr><tr><td><a href="41001i284.htm">Phenytoin</a></td><td class="cBV"><b>metabolism of  corticosteroids accelerated by phenytoin (reduced effect)</b></td><td></td></tr><tr><td><a href="41001i199.htm">Rifamycins</a></td><td class="cBV"><b>metabolism of  corticosteroids accelerated by rifamycins (reduced effect)</b></td><td>Interactions do not apply to rifaximin</td></tr><tr><td><a href="41001i400.htm">Ritonavir</a></td><td>plasma concentration of  corticosteroids possibly increased by ritonavir </td><td></td></tr><tr><td><a href="41001i1034.htm">Sodium Benzoate</a></td><td> corticosteroids possibly reduce effects of sodium benzoate </td><td></td></tr><tr><td><a href="41001i765.htm">Sodium Nitroprusside</a></td><td> corticosteroids antagonise hypotensive effect of sodium nitroprusside </td><td></td></tr><tr><td><a href="41001i1033.htm">Sodium Phenylbutyrate</a></td><td> corticosteroids possibly reduce effects of sodium phenylbutyrate </td><td></td></tr><tr><td><a href="41001i848.htm">Somatropin</a></td><td> corticosteroids may inhibit growth-promoting effect of somatropin </td><td></td></tr><tr><td><a href="41001i720.htm">Sympathomimetics, Beta<sub>2</sub></a></td><td>increased risk of hypokalaemia when  corticosteroids given with high doses of beta<sub>2</sub> sympathomimetics—see Hypokalaemia, <a title="CSM hypokalaemia (target-block)" href="2878.htm#_2878.8">section 3.1.1.1</a></td><td></td></tr><tr><td><a href="41001i734.htm">Theophylline</a></td><td>increased risk of hypokalaemia when  corticosteroids given with theophylline </td><td></td></tr><tr><td><a href="41001i757.htm">Vaccines</a></td><td class="cBV"><b>high doses of  corticosteroids impair immune response to vaccines , avoid concomitant use with live vaccines (see under Active immunity, <a title="target-block: contra-indications" href="6451.htm#_6451.4">section 14.1</a>)</b></td><td>For a general warning on live vaccines and high doses of corticosteroids or other immunosuppressive drugs, see <a title="target-block: contra-indications" href="6451.htm#_6451.4">section 14.1</a>; for advice on live vaccines and immunoglobulins, see under Normal Immunoglobulin, <a title="Normal immunoglobulin notes (target-block)" href="202710.htm#_202708">section 14.5.1</a></td></tr><tr><td><a href="41001i626.htm">Vecuronium</a></td><td> corticosteroids possibly antagonise effects of vecuronium </td><td></td></tr></tbody></table></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="41001i497.htm">Previous: Fluticasone</a> | <a class="top" href="41001i491.htm#">Top</a> | <a accesskey="]" href="41001i492.htm">Next: Methylprednisolone</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>